The stock is rerating because it’s moving from “COVID vaccine story” to a real platform: first-in-vivo CAR-T (mRNA-6007) plus ...
Strive (NASDAQ: ASST) has announced that it expects to raise the size of its at-the-market offering programs for both its Class A common stock and its SATA preferred shares by $2.1 billion each. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results